Е. Р. Черных

ORCID: 0000-0003-2346-6279
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Reproductive System and Pregnancy
  • Immune Response and Inflammation
  • RNA Interference and Gene Delivery
  • Hematopoietic Stem Cell Transplantation
  • Mesenchymal stem cell research
  • Monoclonal and Polyclonal Antibodies Research
  • Multiple Myeloma Research and Treatments
  • Phagocytosis and Immune Regulation
  • Cancer Cells and Metastasis
  • Macrophage Migration Inhibitory Factor
  • Cancer Immunotherapy and Biomarkers
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Pregnancy and preeclampsia studies
  • Tryptophan and brain disorders
  • Liver Disease Diagnosis and Treatment
  • Cytokine Signaling Pathways and Interactions
  • CAR-T cell therapy research
  • Glioma Diagnosis and Treatment
  • Tuberculosis Research and Epidemiology
  • Chemokine receptors and signaling
  • Neonatal Respiratory Health Research

Research Institute of Fundamental and Clinical Immunology
2016-2025

Russian Academy of Sciences
2007-2020

Cellular Research (United States)
2020

Institute of Immunology
2012-2014

Academy of Medical Sciences
2002-2014

Our objective was to evaluate the safety and clinical efficacy of autologous M2 macrophage transplantation in nonacute stroke patients. We also evaluated whether intrathecal administration macrophages influences production cytokines by peripheral blood cells levels correlate with severity responsiveness cell therapy. In this study, 13 patients (12 males 1 female a median age 63 years) diagnosed ischemic (n = 10) or hemorrhagic 3) were subjected therapy (study group). On average, 21.9 × 10(6)...

10.3727/096368915x690279 article EN Cell Transplantation 2016-02-05

Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of cell procedures is an important task professional associations devoted therapy. The Chinese Branch the International Association Neurorestoratology (IANR) completed first set guidelines governing application neurorestoration in 2011. IANR and (CANR) collaborated propose current version "Clinical Therapy Guidelines Neurorestoration (IANR/CANR 2017)". council...

10.1177/0963689717746999 article EN cc-by-nc Cell Transplantation 2018-02-01

Rearrangement of the immune system during pregnancy is a strictly controlled, dynamic process in which first and third trimesters are, respectively, pro-inflammatory, anti-inflammatory periods. However, monocyte involvement regulating pro/anti-inflammatory balance remains poorly understood. The functional phenotype monocytes known to depend on their subsets assessed by CD14 CD16 expression, associated with expression M1(CCR2)- M2(CD206) molecules, pro- activity, respectively. Here we have...

10.15789/1563-0625-cot-2990 article EN cc-by Medical Immunology (Russia) 2025-01-08

In this part of the study, first component concept “natural genome reconstruction” is being proven. It was shown with mouse and human model organisms that CD34+ hematopoietic bone marrow progenitors take up fragments extracellular double-stranded DNA through a natural mechanism. known process internalization involves glycocalyx structures, which include glycoproteins/protein glycans, glycosylphosphatidylinositol-anchored proteins scavenger receptors. The bioinformatic analysis conducted...

10.18699/vjgb-24-106 article EN cc-by Vavilov Journal of Genetics and Breeding 2025-01-26

Despite the end of COVID-19 pandemic, there still remain risks new aggressive strains coronavirus. As human population increases progressively, it is mandatory to ensure both preventive measures and an immediate response emerging infectious threats. Another essential component for rapidly restraining a possible pandemic development anticoronaviral therapeutics. In present study, capabilities Gc protein-derived macrophage-activating factor (GcMAF) are characterized. It demonstrated that...

10.3390/covid5030036 article EN cc-by COVID 2025-03-08

It has been established previously that up to 40% of mouse CD34+ hematopoietic stem cells are capable internalizing exogenous dsDNA fragments both in vivo and ex vivo. Importantly, when mice treated with a combination cyclophosphamide dsDNA, the repair interstrand crosslinks progenitors is attenuated, their pluripotency altered. Here we show for first time among various actively proliferating mammalian cell populations there subpopulations fragments. In context cancer, such...

10.4161/cbt.29854 article EN Cancer Biology & Therapy 2014-07-17

Abstract It was shown that IgGs from the sera of 2–7‐month‐old control non‐autoimmune (CBA x C57BL)F1 and BALB/c mice 2–3‐month‐old autoimmune prone MRL‐lpr/lpr (conditionally healthy mice) are catalytically inactive. During spontaneous development deep systemic lupus erythematosus (SLE)‐like pathology a specific reorganization immune system these leads to conditions associated with production hydrolyzing DNA, ATP polysaccharides low catalytic activities pre‐diseased mice).A significant...

10.1111/j.1582-4934.2007.00048.x article EN other-oa Journal of Cellular and Molecular Medicine 2007-05-01

Recent studies demonstrated that myeloid-derived suppressor cells (MDSCs) are involved in the pathogenesis and progression of multiple myeloma (MM). Nevertheless, data on quantitative functional changes MDSCs during standard MM treatment remain poorly understood. Here, we determined monocytic (M-MDSC; CD14

10.1016/j.heliyon.2024.e26362 article EN cc-by-nc Heliyon 2024-02-16

Macrophages are the immune cells of high-immunological plasticity, which can exert both pro- and anti-inflammatory activity, as well repolarize their phenotype to opposite or neutral one. In this regard, M2 macrophages tumor-associated stroma (TAS) a promising therapeutic target in treating malignant neoplasms. Using FACS assay, we have estimated CD11b+/Ly-6G+/Ly-6C+ fraction from peritoneum TAS intact healthy mice those with developed Lewis carcinoma, untreated treated according Karanahan...

10.1155/2024/7484490 article EN cc-by Journal of Immunology Research 2024-02-29

Currently, there is a lack of effective therapeutic methods to restore neurological function for chronic complete spinal cord injury (SCI) by conventional treatment. Neurorestorative strategies with positive preclinical results have been translated the clinic, and some patients gotten benefits their quality life has improved. These include cell therapy, neurostimulation or neuromodulation, neuroprosthesis, neurotization nerve bridging, neurorehabilitation. The aim this consensus 31 experts...

10.3727/096368914x684952 article EN Cell Transplantation 2014-01-01

Stem cell-based therapy is considered to be a new approach for the treatment of cerebral palsy (CP). Given potent anti-inflammatory activity and high regenerative potential M2 macrophages, these cells may an alternative source cell transplantation. To evaluate safety efficacy autologous we conducted pilot clinical trial in 21 children with severe CP. The primary outcome measure was safety, which included assessment mortality any cause, immediate adverse reactions, serious effects...

10.3727/096368914x684925 article EN Cell Transplantation 2014-01-01

// Ekaterina A. Potter 1 , Evgenia V. Dolgova Anastasia S. Proskurina Alexandra M. Minkevich Yaroslav R. Efremov 1, 2 Oleg Taranov 3 Vladimir Omigov Valeriy P. Nikolin Nelly Popova Sergey I. Bayborodin Alexander Ostanin 4 Elena Chernykh Nikolay Kolchanov Mikhail Shurdov 5 Bogachev Institute of Cytology and Genetics, Siberian Branch the Russian Academy Sciences, Novosibirsk 630090, Russia Department Natural State University, The Research Center Virology Biotechnology VECTOR, 630559, Clinical...

10.18632/oncotarget.7311 article EN Oncotarget 2016-02-10

Immature hematopoietic progenitors are a constant source for renewal of hemocyte populations and the basic component tissue cell repair apparatus. A unique property these cells internalizing extracellular double-stranded DNA has been previously shown. The leukostimulatory effect demonstrated in our pioneering studies was considered to be due feature this cell. In present research, we have analyzed effects genome reconstructor preparation (DNAgr), DNAmix, human recombinant angiogenin on both...

10.1590/1414-431x2024e13072 article EN cc-by Brazilian Journal of Medical and Biological Research 2024-01-01

Systemic lupus erythematosus (SLE) is an immune-mediated disease that responsive to suppression or modulation of the immune system. Patients with SLE who experience persistent multiorgan dysfunction, despite standard doses intravenous cyclophosphamide (Cy), represent a subset patients at high risk early death. We investigated efficacy and toxicity high-dose immunosuppression autologous hematopoietic stem cell transplantation (SCT) treat such patients. Six (all female, age 15-29 years) severe...

10.1191/0961203304lu491oa article EN Lupus 2004-02-01

Abstract Background Immunization of mice with tumor homogenate after combined treatment cyclophosphamide (CP) and double-stranded DNA (dsDNA) preparation is effective at inhibition growth challenged the treatment. It was assumed that this might be due to activation antigen-presenting cells. The purpose develop improved antitumor strategy using mice. We studied action cytostatics doxorubicin (Dox) plus CP subsequent dsDNA on growth. Methods Three-month old CBA/Lac were used in experiments....

10.1186/1479-0556-8-7 article EN cc-by Genetic Vaccines and Therapy 2010-11-01

The phenotypic and functional features of human M2 macrophages, in particular, their immunosuppressive activity, can considerably vary depending on polarizing stimulus. This study was aimed at the investigation cytokine production pro-apoptogenic/inhibitory molecule expression macrophages generated with GM-CSF using either standard conditions (M1) or deficiency serum/growth factors (M2-LS cells). In contrast to M1, M2-LS cells were characterized by an enhanced content CD206(+), B7-H1(+),...

10.1111/sji.12401 article EN Scandinavian Journal of Immunology 2015-12-18
Coming Soon ...